Compounds of Formula (I) and methods for inhibiting kinases, including spleen tyrosine kinases, are disclosed. Also disclosed are methods for treating a kinase-mediated disease or condition by administering to a subject a therapeutically effective amount of the compound of Formula (I).
公式(I)的化合物和抑制激酶的方法,包括脾
酪氨酸激酶。还公开了通过向受试者投与公式(I)的化合物的治疗有效量来治疗激酶介导疾病或状况的方法。